Back to Screener

Healthcare

Ascendis Pharma A/S(ASND)

Live Price

Offline

$261.58

+9.90% today

1Y Change

+34.03%

Window

Jun 27, 2025 โ†’ Jun 18, 2026

Market Cap
$12.01B
Revenue Growth
+90.2%
EPS Growth
+44.6%
Dividend Yield
0.0%

Coverage: 245 bars ยท Jun 27, 2025 โ†’ Jun 18, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Ascendis Pharma A/S (ASND) is a Healthcare stock with a market cap of $12.01B. The stock last traded around $261.58 and up 34.0% across the available one-year price window (Jun 27, 2025 โ†’ Jun 18, 2026). Baseline metrics include revenue growth of +90.2%, EPS growth of +44.6%, a dividend yield of 0.0%. What stands out right now is revenue +90.2%, EPS +44.6%, free cash flow +114.2% with operating margin -19.0% and ROIC -19.0%. Valuation already assumes a fairly strong business story at price/sales 16.7. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines ASND price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Edge

ASND vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

ASND

โ€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

ASND Max Drawdown

-17.62%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for ASND and SPY.

Calendar-year return history is still loading or unavailable.

Earnings Reports

๐Ÿ“… Last reportedMay 7, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”Report
โ€”
May 7, 26
โ€”
Est 0.33
โ€”
โ€”
Est 376114.5B
โ€”
May 7
โ€”
Feb 11, 26
โœ—
-0.64
Est -0.06
-966.7%
344844.1B
Est 292258.1B
+18.0%
Feb 11
โ€”
Nov 12, 25
โœ—
-1.17
Est -0.41
-185.4%
250218.8B
Est 302600.6B
-17.3%
Nov 12
โ€”
Aug 7, 25
โœ“
-0.93
Est -1.42
+34.5%
186088.5B
Est 233118.2B
-20.2%
Aug 7
โ€”
May 1, 25
โœ—
-1.66
Est -1.56
-6.4%
110670.8B
Est 153476.7B
-27.9%
May 1
โ€”
Feb 12, 25
โœ“
-0.68
Est -1.20
+43.3%
180088.3B
Est 125416.0B
+43.6%
Feb 12
โ€”
Nov 14, 24
โœ“
-1.81
Est -1.83
+1.1%
63427.2B
Est 74137.8B
-14.4%
Nov 14
โ€”
Sep 3, 24
โœ—
-2.05
Est -1.54
-33.1%
38706.5B
Est 37575.6B
+3.0%
Sep 3
โ€”
May 2, 24
โœ—
-2.48
Est -1.62
-53.3%
103017.0B
Est 92355.9B
+11.5%
May 2
โ€”
Feb 7, 24
โœ“
-1.66
Est -2.19
+24.1%
151439.0B
Est 111120.1B
+36.3%
Feb 7
โ€”
Nov 7, 23
โœ—
-3.08
Est -2.55
-21.0%
50668.5B
Est 55320.6B
-8.4%
Nov 7
โ€”
Aug 16, 23
โœ“
-1.54
Est -3.09
+50.2%
51701.4B
Est โ€”
โ€”
Aug 16
โ€”
Apr 27, 23
โœ“
-2.18
Est -2.93
+25.6%
36518.4B
Est 25783.9B
+41.6%
Apr 27
โ€”
Feb 16, 23
โœ—
-3.96
Est -2.74
-44.5%
24662.8B
Est 22048.0B
+11.9%
Feb 16
โ€”
Nov 2, 22
โœ—
-3.05
Est -2.52
-21.0%
14931.8B
Est 13597.2B
+9.8%
Nov 2
โ€”
Aug 10, 22
โœ“
-1.50
Est -2.19
+31.5%
6443.5B
Est 6006.9B
+7.3%
Aug 10
โ€”
May 11, 22
โœ—
-2.31
Est -2.09
-10.5%
7552.6B
Est 5253.7B
+43.8%
May 11
โ€”
Mar 2, 22
โœ“
-2.06
Est -2.57
+20.1%
5551.8B
Est 3381.2B
+64.2%
Mar 2
โ€”
Nov 10, 21
โœ“
-1.69
Est -2.63
+35.8%
1291.8B
Est 1702.8B
-24.1%
Nov 10
โ€”
Aug 25, 21
โœ—
-3.01
Est -2.75
-9.4%
1212.5B
Est 1304.2B
-7.0%
Aug 25
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.

Read the earnings calendar guideOpen the market calendar